ACETYLCYSTEINE LYSINE
| Brand name | LEGUBETI |
|---|---|
| Active ingredient | ACETYLCYSTEINE LYSINE |
| Strength | EQ 500MG BASE/PACKET |
| Dosage form | FOR SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2024 |
| Marketing status | DISCN |
| Code | Expires |
|---|---|
| NP | February 2027 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.